• Beximco Completes Sanofi Bangladesh Acquisition

News & Views

Beximco Completes Sanofi Bangladesh Acquisition

Nov 17 2021

Beximco Pharmaceuticals Ltd has announced that the company has now completed its acquisition of the majority stake in Sanofi Bangladesh, in line with the company’s strategy to expand core capabilities and product offerings.

Mr Nazmul Hassan MP, Beximco Pharma MD, commented: "The completion of this deal - the second acquisition in Beximco Pharma’s history - is a significant moment. We have a clear strategy to continue our diversification and expansion while strengthening our position as a market-leading pharma company in Bangladesh. The acquisition of a majority stake in Sanofi Bangladesh is precisely in line with this strategy, strengthening our position in key therapeutic areas to drive sustainable revenue and profit growth. We look forward to welcoming over 800 skilled and diligent Sanofi Bangladesh employees to our existing workforce. As an enlarged group, we are excited to continue our growth trajectory by delivering affordable treatments and breakthrough therapies in our growing domestic market."

More information online

Digital Edition

International Labmate 48.6 - September 2023

September 2023

In This Edition Chromatography Articles - Faster and automated analysis of aroma compounds in cosmetics Mass Spectrometry & Spectroscopy Articles - Frequently Asked Questions (FAQ) abou...

View all digital editions


19th Confocal Raman Imaging Symposium

Sep 25 2023 Ulm, Germany

Analitica Latin America

Sep 26 2023 Sao Paolo, Brazil


Sep 26 2023 Basel, Switzerland

PTA - Chelyabinsk 2023

Sep 27 2023 Chelyabinsk, Russia

Asia Labex

Oct 05 2023 Gandhinagar, India

View all events